E
ENDRA Life Sciences Inc. (NDRA)
NCM – Real Time Price. Currency in USD
5.81
+0.74 (14.60%)
At close: May 12, 2026, 4:00 PM EDT
5.81
0.00 (0.00%)
After-hours: May 12, 2026, 7:42 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
5.81
+0.74 (14.60%)
At close: May 12, 2026, 4:00 PM EDT
5.81
0.00 (0.00%)
After-hours: May 12, 2026, 7:42 PM EDT
ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is involved in the development of thermo-acoustic enhanced ultrasound technology that uses pulsed energy source such as radio frequency to transmit energy deep into tissue and generate ultrasonic waves to create high-contrast images for use in the treatment of non-alcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion analysis. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.
| Name | Position |
|---|---|
| Dr. Jonathan Behr Ph.D. | Co-Founder |
| Mr. Alexander Y. Tokman | CEO & Chairman |
| Mr. Idan Steinberg | Head of Engineering |
| Mr. Richard Jacroux | CFO & Secretary |
| Mr. Scott Sober | Head of Operations |
| Mr. Ziad Rouag J.D. | Head of Regulatory & Clinical Affairs |
| Date | Type | Document |
|---|---|---|
| 2026-04-21 | 8-K | ea0287103-8k_endra.htm |
| 2026-03-31 | 10-K | ea0283994-10k_endra.htm |
| 2026-03-25 | 8-K | ea0283331-8k_endra.htm |
| 2025-12-15 | 8-K | ea0269386-8k_endra.htm |
| 2025-11-28 | 8-K | ea0267731-8k_endra.htm |
| 2025-11-14 | 10-Q | ea0265291-10q_endra.htm |
| 2025-11-06 | S-3 | ea0263382-s3_endra.htm |
| 2025-10-28 | DEFA14A | shn_defa14a.htm |
| 2025-10-24 | D | |
| 2025-10-23 | 8-K | endra_8k.htm |